Form D · Other
Reflexion Pharmaceuticals, Inc.
San Francisco, CA · CIK 0001534808
Offering snapshot reported Dec 1, 2011 · SEC filing
- Reported sold
- $1.14M Offering amount: $1.25M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 31, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 1, 2011 | Initial | $1,143,926 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-169481
Common Stock Offering
Source: Form D, filed Dec 1, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dana B. Ault Riche' | Director, Executive, Promoter |
| Hans Peter Biemann | Promoter |
| Heng Wei Chang | Promoter |
| Peter J. Crowley | Promoter |
| Patrick Dentinger | Promoter |
| Douglas C. Floren | Promoter |
| Ismael Hidalgo | Promoter |
| John S. Kenney | Promoter |
| Stephen B.H. Kent | Director, Promoter |
| Gurdev Singh Sidhu | Promoter |
| Sachdev Sidhu | Director, Promoter |
| Joseph Siletto | Promoter |
| Dario Slavazza | Promoter |
| Richard Van Den Broek | Promoter |
| Albertus W. Van Den Broek | Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
201 Sansome Street Suite 702
San Francisco, CA, 94104
San Francisco, CA, 94104